Inventor
PAUL J. HERGENROTHER
Inventor
US
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes23%
C07DHeterocyclic compounds19%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
Y02ATechnologies for adaptation to climate change6%
C07BGeneral methods of organic chemistry4%
C07CAcyclic or carbocyclic compounds4%
C07HSugars2%
C07JSteroids2%
C09BOrganic dyes or closely-related compounds for producing dyes, e.g. pigments2%
PatentTitleYear
12,433,885Procaspase combination therapy for glioblastoma202512,336,992PAC-1 combination therapy202512,234,240Substituted imidazo[5,1-d][1,2,3,5]tetrazines for the treatment of cancer202512,235,275Fluorescent substrates for poly(ADP-ribosyl) hydrolases202512,180,159Activators of the unfolded protein response202412,180,198Ribocil C antibiotics effective for Gram-negative pathogens202412,168,006Cancer therapy by degrading dual MEK signaling202412,090,153Combination therapy for the treatment of uveal melanoma202411,926,877Saliva-based molecular testing for SARS-CoV-2202411,858,946Small molecules active against gram-negative bacteria202411,844,798Procaspase combination therapy for glioblastoma202311,833,147Procaspase 3 activation by combination therapy202311,691,967Antibiotics effective for gram-negative pathogens202311,612,598Compounds and methods for the treatment of cancer202311,584,718Activators of the unfolded protein response202311,530,457Saliva-based molecular testing for SARS-CoV-2202211,510,919Cancer therapy by degrading dual MEK signaling202211,274,106Topoisomerase inhibitors with antibacterial and anticancer activity2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to UNIV ILLINOIS (18)· patent assignee history
2022–2025Based in US· patent location history
2023–2025Patents assigned to VANQUISH ONCOLOGY INC (3)· patent assignee history
2023–2025Patents assigned to UNIV JOHNS HOPKINS (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV ILLINOIS | 18 | 2022–2025 |
| VANQUISH ONCOLOGY INC | 3 | 2023–2025 |
| UNIV JOHNS HOPKINS | 2 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 18 | 2022–2025 |